References
- Sroussi HY, Epstein JB, Bensadoun RJ, Saunders DP, Lalla RV, Migliorati CA, et al. Common oral complications of head and neck cancer radiation therapy: mucositis, infections, saliva change, fibrosis, sensory dysfunctions, dental caries, periodontal disease, and osteoradionecrosis. Cancer Med 2017; 6: 2918-31. doi: 10.1002/cam4.1221
- Sommat K, Ong WS, Hussain A, Soong YL, Tan T, Wee J, et al. Thyroid V40 predicts primary hypothyroidism after intensity modulated radiation therapy for nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 2017; 98: 574-80. doi: 10.1016/j.ijrobp.2017.03.007
- Diaz R, Jaboin JJ, Morales-Paliza M, Koehler E, Phillips JG, Stinson Set, et al. Hypothyroidism as a consequence of intensity-modulated radiotherapy with concurrent taxane-based chemotherapy for locally advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys 2010; 77: 468-76. doi: 10.1016/j.ijrobp.2009.05.018
- Kim MY, Yu T, Wu HG. Dose-volumetric parameters for predicting hypothyroidism after radiotherapy for head and neck cancer. Jpn J Clin Oncol 2014; 44: 331-7. doi: 10.1093/jjco/hyt235
- Mulholland GB, Zhang H, Nguyen NT, Tkacyzk N, Seikaly H, O’Connell D, et al. Optimal detection of hypothyroidism in early stage laryngeal cancer treated with radiotherapy. J Otolaryngol Head Neck Surg 2015; 44: 34. doi: 10.1186/s40463-015-0085-3
- Tell R, Lundell G, Nilsson B, Sjödin H, Lewin F, Lewensohn R. Long-term incidence of hypothyroidism after radiotherapy in patients with head-and-neck cancer. Int J Radiat Oncol Biol Phys 2004; 60: 395-400. doi: 10.1016/j. ijrobp.2004.03.020
- Chyan A, Chen J, Shugard E, Lambert L, Quivey JM, Yom SS. Dosimetric predictors of hypothyroidism in oropharyngeal cancer patients treated with intensity-modulated radiation therapy. Radiat Oncol 2014; 9: 269. doi: 10.1186/s13014-014-0269-4
- Ling S, Bhatt AD, Brown NV, Nguyen P, Sipos JA, Chakravarti A, et al. Correlative study of dose to thyroid and incidence of subsequent dysfunction after head and neck radiation. Head Neck 2017; 39: 548-54. doi: 10.1002/hed.24643
- Kanyilmaz G, Aktan M, Koc M, Demir H, Demir LS. Radiation-induced hypothyroidism in patients with breast cancer: a retrospective analysis of 243 cases. Med Dosim 2017; 42: 190-6. doi: 10.1016/j.meddos.2017.03.003
- Vogelius IR, Bentzen SM, Maraldo MV, Petersen PM, Specht L. Risk factors for radiation-induced hypothyroidism: a literature-based meta-analysis. Cancer 2011; 117: 5250-60. doi: 10.1002/cncr.26186
- Sachdev S, Refaat T, Bacchus ID, Sathiaseelan V, Mittal BB. Thyroid V50 highly predictive of hypothyroidism in head-and-neck cancer patients treated with intensity-modulated radiotherapy (IMRT). Am J Clin Oncol 40: 413-7. doi: 10.1097/COC.0000000000000165
- Lin AJ, Zhang J, Cho-Lim J, Inouye W, Lee SP. Postradiation hypothyroidism in head and neck cancers: A Department of Veterans Affairs single-institution case-control dosimetry study. Med Dosim 2018; 44: 56-60. doi: 10.1016/j.meddos.2018.02.001
- Wiggenraad R, Mast M, van Santvoort J, Hoogendoorn M, Struikmans H. ConPas: a 3-D conformal parotidgland-sparing irradiation technique for bilateral neck treatment as an alternative to IMRT. Strahlenther Onkol 2005; 181: 673-82. doi: 10.1007/s00066-005-1413-8
- Colevas AD, Read R, Thornhill J, Adak S, Tishler R, Busse P, et al. Hypothyroidism incidence after multimodality treatment for stage III and IV squamous cell carcinomas of the head and neck. Int J Radiat Oncol Biol Phys 2001; 51: 599-604. doi:10.1016/s0360-3016(01)01688-1
- Boomsma MJ, Bijl HP, Langendijk JA. Radiation-induced hypothyroidism in head and neck cancer patients: a systematic review. Radiother Oncol 2011; 99: 1-5. doi: 10.1016/j.radonc.2011.03.002
- Alterio D, Jereczek-Fossa BA, Franchi B, D’Onofrio A, Piazzi V, Rondi E, et al. Thyroid disorders in patients treated with radiotherapy for head-and-neck cancer: a retrospective analysis of seventy-three patients. Int J Radiat Oncol Biol Phys 2007; 67: 144-50. doi: 10.1016/j.ijrobp.2006.08.051
- Akgun Z, Atasoy BM, Ozen Z, Yavuz D, Gulluoglu B, Sengoz M, et al. V30 as a predictor for radiation-induced hypothyroidism: a dosimetric analysis in patients who received radiotherapy to the neck. Radiat Oncol 2014; 9: 104. doi: 10.1186/1748-717X-9-104
- Cella L, Conson M, Caterino M, De Rosa N, Liuzzi R, Picardi M, et al. Thyroid V30 predicts radiation-induced hypothyroidism in patients treated with sequential chemo-radiotherapy for Hodgkin’s lymphoma. Int J Radiat Oncol Biol Phys 2012; 82: 1802-8. doi: 10.1016/j.ijrobp.2010.09.054
- Luo R, Li M, Yang Z, Zhan Y, Huang B, Lu J, et al. Nomogram for radiation-induced hypothyroidism prediction in nasopharyngeal carcinoma after treatment. Br J Radiol 2017; 90: 20160686. doi: 10.1259/bjr.20160686.
- Xu Y, Shao Z, Tang T, Liu G, Yao Y, Wang J, et al. A dosimetric study on radiation-induced hypothyroidism following intensity-modulated radiotherapy in patients with nasopharyngeal carcinoma. Oncol Lett 2018; 16: 6126-32. doi: 10.3892/ol.2018.9332
- Lee V, Chan SY, Choi CW, Kwong D, Lam KO, Tong CC, et al. Dosimetric predictors of hypothyroidism after radical intensity-modulated radiation therapy for non-metastatic nasopharyngeal carcinoma. Clin Oncol (R Coll Radiol) 2016; 28: e52-60. doi: 10.1016/j.clon.2016.05.004
- Luo R, Wu VWC, He B, Gao X, Xu Z, Wang D et al. Development of a normal tissue complication probability (NTCP) model for radiation-induced hypothyroidism in nasopharyngeal carcinoma patients. BMC Cancer 2018; 18: 575. doi: 10.1186/s12885-018-4348-z
- Jereczek-Fossa BA, Alterio D, Jassem J, Gibelli B, Tradati N, Orecchia R. Radiotherapy induced thyroid disorders. Cancer Treat Rev 2004; 30: 369-84. doi: 10.1016/j.ctrv.2003.12.003